Trial of two tenofovir-containing regimens for HIV/HBV co-infection: Insights from ALLIANCE | Latest news for Doctors, Nurses and Pharmacists | Pharmacy - MIMS
8/24/2022 12:00:00 AM2 years 8 months ago
by Roshini Claire Anthony
by Roshini Claire Anthony
The triplet combination of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) is as good as dolutegravir + emtricitabine/tenofovir disoproxil f...
The triplet combination of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) is as good as dolutegravir + emtricitabine/tenofovir disoproxil fumarate (DTG+F/TDF) in terms of efficacy for HIV … [+4041 chars]
full article...